Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014

Scientists working in the field of Alzheimer's disease and, in particular, cognitive enhancers, are very productive. The review "Drugs interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs" was accepted in October 2012. In the last 20 months, new targets for the potential treatment of Alzheimer's disease were identified. Enormous progress was realized in the pharmacological characterization of natural products with cognitive enhancing properties. This review covers the evolution of research in this field through May 2014.


Published in:
Journal Of Alzheimers Disease, 42, 4, 1079-1149
Year:
2014
Publisher:
Amsterdam, Ios Press
ISSN:
1387-2877
Keywords:
Laboratories:




 Record created 2014-12-30, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)